Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Cancer Research|February 1, 1985
Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorinesN E Sladek, J E Low, G J LandkamerCancer Treatment Reports|October 1, 1984
Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantationN E Sladek, D Doeden, J F Powers, et al.Journal of Chromatography|July 1, 1978
Microdetermination of caffeine in blood by gas chromatography--mass spectrometryR L Merriman, A Swanson, M W Anders, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1978
Differential effects of Walker 256 carcinosarcoma cells growing subcutaneously, intramuscularly, or intraperitoneally on hepatic microsomal mixed-function oxygenase activityN E Sladek, B E Domeyer, R L Merriman, et al.Lipids|February 1, 1978
Inhibition of diacylglycerol:CDPcholine cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetateS Parthasarathy, R K Cady, D S Kraushaar, et al.Leukemia & Lymphoma|May 1, 1994
Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamideF M Uckun, M Chandan-Langlie, P A Dockham, et al.Cancer Treatment Reports|October 1, 1980
PLasma half-life and urinary excretion of cyclophosphamide in childrenN E Sladek, J Priest, D Doeden, et al.Development (Cambridge, England)|June 1, 1992
Asymmetrical retinoic acid synthesis in the dorsoventral axis of the retinaP McCaffery, M O Lee, M A Wagner, et al.Leukemia & Lymphoma|December 1, 1995
Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cellsJ S Moreb, C Turner, L Sreerama, et al.Cancer Research|June 15, 1987
Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorinesF R Kohn, G J Landkamer, C L Manthey, et al.Pageof 5